Upload Avatar (500 x 500)
Wenjie Guo
guowj@nju.edu.cn
Chinese, English
Jiangsu
Nanjing University
Life Sciences
  • 2003/09-2007/06 Bachelor in Pharmaceutical Engineering: Jiangsu University
  • 2007/09-2010/06 Master in Pharmacognosy: Jiangsu University
  • 2010/09-2013/06 PhD in Pharmacology: Nanjing University
  • Achievement: First Prize in Natural Science Award by Ministry of Education
  • 2013/08-2015/06 - Jiangsu University - Lecturer
  • 2015/07-2022/01 - Nanjing University - Associate Professor
  • 2020/09-Present - Nanjing University - Doctoral Supervisor
  • 2022/01-Present - Nanjing University - Professor
  • 2022: Second Prize in Jiangsu Medical Science and Technology Award
  • 2021: Excellent Teaching Team of Jiangsu Higher Education 'Qinglan Project'
  • 2019: Servier Young Pharmacologist Award by Chinese Pharmacological Society
  • 2018: Second Prize in Jiangsu Education and Research Achievement
  • 2018: First Prize in Natural Science Award by Ministry of Education
  • 2015: 19th Young Pharmacologist Award by Chinese Pharmacological Society
  • 2015: Excellent Doctoral Dissertation of Nanjing University
  • 2015: Excellent Doctoral Dissertation of Jiangsu Province
Mechanisms of inflammation resolution and drug regulation
  • Allosterically activating SHP2 using oleanolic acid inhibited the STAT3-Th17 axis and ameliorated colitis, Jinbo Hu, Wen Liu, Yi Zou, Chenyang Jiao, Jiazhen Zhu, Jianjun Zou, Yang Sun, Qiang Xu, Wenjie Guo, 2024
  • IDO1 inhibition promotes activation of tumor-intrinsic STAT3 pathway and induces adverse tumor-protective effects, Longbo Yu, Lingyan Xu, Yunjie Chen, Yicheng Rong, Yi Zou, Shushan Ge, Tiancong Wu, Yisheng Lai, Qiang Xu, Wenjie Guo, Wen Liu, 2024
  • A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway, Wu Xiaohan, Xu Lingyan, Li Xiaofei, Zhou Yirui, Han Xiao, Zhang Wei, Wang Weicheng, Wenjie Guo, Liu Wen, Xu Qiang, Gu Yanhong, 2023
  • PCSK9 inhibition interrupts the cross talk between keratinocytes and macrophages and prevents UVB-induced skin damage, Chao Luan, He Yingxue, Liu Wen, Rong Yicheng, Gao Jian, Xu Kang, Yu Hui, Hu Yu, Zhang Jiaan, Chen Kun, Wenjie Guo, 2023
  • 嘌呤霉素敏感的氨肽酶结构与功能研究进展, 焦晨阳,李艳,徐强,郭文洁, 2023
  • Spirodalesol analog 8A inhibits NLRP3 inflammasome activation and attenuates inflammatory disease by directly targeting adaptor protein ASC, Wen Liu, Jiashu Yang, Shihao Fang, Chenyang Jiao, Jianhua Gao, Aihua Zhang, Tiancong Wu, Renxiang Tan, Qiang Xu, Wenjie Guo, 2022
  • Apo-form selective inhibition of indoleamine-2,3-dioxygenase for tumor immunotherapy, Liu Wen, Zou Yi, Li Kaiming, Zhong Haiqing, Yu Longbo, Ge Shushan, Lai Yisheng, Xianchi Dong, Xu Qiang, Guo Wenjie, 2022
  • DNA damage repair promotion in colonic epithelial cells by Andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11‒induced intestinal mucositis, Yuanyuan Wang, Bin Wei, Danping Wang, Jingjing Wu, Jianhua Gao, Haiqing Zhong, Yang Sun, Qiang Xu, Wen Liu, Yanhong Gu, Wenjie Guo, 2022
  • SHP2-mediated inhibition of DNA repair contributes to cGAS-STING activation and chemotherapeutic sensitivity in colon cancer, Wei Bin, Xu Lingyan, Wenjie Guo, Wang Yuanyuan, Wu Jingjing, Li Xiaofei, Cai Xiaomin, Hu Jinbo, Wang Meijing, Xu Qiang, Liu Wen, Gu Yanhong, 2021
Inflammation Resolution Mechanisms Drug Regulation Nlrp3 Cgas Colitis Cancer Therapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.